Table 1: Group demographics.
|
DEC (n=38) |
PTSD (n=33) |
|
| DESCRIPTIVES |
|
|
p |
| Male, f (%) |
29 (76%) |
33 (100%) |
.002* |
| Age, M (SD) |
30.7 (6.8) |
33.6 (6.8) |
.070 |
| Education, M (SD) |
15.5 (2.1) |
14.0 (1.8) |
.002* |
| Race, f (%) |
|
|
.240 |
| Caucasian |
29 (76%) |
20 (61%) |
|
| African Am |
2 (5%) |
7 (21%) |
|
| Hispanic/Latino |
3 (8%) |
2 (6%) |
|
| Asian |
2 (5%) |
0 |
|
| Native Am |
0 |
1 (3%) |
|
| Other |
2 (5%) |
3 (9%) |
|
| Combat Exposure |
7.1 (9.5) |
28.3 (8.2) |
<.001* |
| Childhood Experiences |
55.3 (13.3) |
53.9 (8.9) |
.595 |
| PSYCHOLOGICAL HEALTH |
|
|
|
| Posttraumatic Stress |
9.4 (12.8) |
47.1 (17.8) |
<.001* |
| Alcohol Use |
5.8 (4.9) |
9.0 (8.5) |
.071 |
| Depression |
32.5 (8.2) |
48.4 (14.8) |
<.001* |
| Anxiety |
30.6 (6.8) |
46.7 (15.2) |
<.001* |
| Daytime Sleepiness |
8.8 (3.3) |
12.3 (5.3) |
.003* |
| MEDICATION, f (%) |
|
|
∆% |
| Antidepressants |
4 (10.5) |
9 (27.3) |
16.8 |
| 2 or more |
0 |
7 (21.2) |
21.2 |
| Antipsychotics |
1 (2.6) |
3 (9.1) |
6.5 |
| Benzodiazepines |
0 |
5 (15.2) |
15.2 |
| Mood stabilizers |
0 |
0 |
0 |
| Stimulant |
1 (2.6) |
1 (3.0) |
0.4 |
| Hypnotic (Nonbenzodiazepine) |
0 |
5 (15.2) |
15.2 |
| Anxiolytic |
0 |
1 (3.0) |
3.0 |
| Opioid analgesic |
1 (2.6) |
3 (9.1) |
6.5 |
| Female contraceptive |
3 (7.9) |
0 |
-7.9 |
| Testosterone |
1 (2.6) |
1 (3.0) |
0.4 |
| PDE5 inhibitors |
0 |
1 (3.0) |
3.0 |
| % Medicated
|
21% |
49% |
28% |
*Significant after Bonferroni correction (p ≤ .005; .05/11).
Note. Posttraumatic Stress = PCL-5; Combat Exposure = CES; Childhood Environment = CE; Alcohol Use = AUDIT; Depression = ZDS; Anxiety = ZAS; Sleepiness = ESS. ∆% = delta (PTSD minus DEC) or group difference in percentage of medication users.